Online Event
Delivering nucleic acids using lipid nanoparticles (LNPs) to target cells has tremendous potential to enable the development of new cell and gene therapies as well as vaccines. LNPs can be used to deliver nucleic acids of various sizes, including RNA molecules, to precise locations in cells to treat cancer and other conditions. As interest and innovation in LNP-based delivery continues to grow, scaling-up manufacturing while ensuring the stability and safety of the therapies and vaccines that are developed